Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| GASR | P32239 | Gastrin/cholecystokinin type B receptor (CCK-B receptor) (CCK-BR) (Cholecystokinin-2 receptor) (CCK2-R) | 7 | Anxiety disorderDiabetes mellitusDiagnostic imaging | Clinical-translation mediationReceptor-signaling mediation | 2 | 0.38 | |||
| GDE1 | Q9NZC3 | Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16) (RGS16-interacting membrane protein) | 2 | Metabolism mediation | 2 | 0.38 | ||||
| LRP1 | Q07954 | Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] | Candidate cardiovascular disease genesCD markersDisease related genes | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 2 | 0.38 | |||
| OPN3 | Q9H1Y3 | Opsin-3 (Encephalopsin) (Panopsin) | G-protein coupled receptorsPredicted membrane proteins | 7 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 2 | 0.38 | |||
| PCD15 | Q96QU1 | Protocadherin-15 | 1 | Adhesion and uptake mediation | 2 | 0.38 | ||||
| PLXA3 | P51805 | Plexin-A3 (Plexin-4) (Semaphorin receptor SEX) | 1 | Adhesion and uptake mediationReceptor-signaling mediation | 2 | 0.38 | ||||
| S6A14 | Q9UN76 | Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) (Amino acid transporter ATB0+) (Solute carrier family 6 member 14) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Rheumatoid arthritis | Clinical-translation mediationFusion and delivery mediation | 2 | 0.38 | ||
| TNR25 | Q93038 | Tumor necrosis factor receptor superfamily member 25 (Apo-3) (Apoptosis-inducing receptor AIR) (Apoptosis-mediating receptor DR3) (Apoptosis-mediating receptor TRAMP) (Death receptor 3) (Lymphocyte-associated receptor of death) (LARD) (Protein WSL) (Protein WSL-1) | 1 | Solid tumour/cancer | Clinical-translation mediationImmune mediation | 2 | 0.38 | |||
| TNR8 | P28908 | Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30) | Cancer-related genesCD markersFDA approved drug targets | 1 | B-cell lymphomaDiabetes mellitusFollicular lymphoma | Clinical-translation mediationImmune mediation | 2 | 0.38 | ||
| ABCA7 | Q8IZY2 | Phospholipid-transporting ATPase ABCA7 (EC 7.6.2.1) (ABCA-SSN) (ATP-binding cassette sub-family A member 7) (Autoantigen SS-N) (Macrophage ABC transporter) | Disease related genesEnzymesHuman disease related genes | 15 | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.38 | |||
| ABCB6 | Q9NP58 | ATP-binding cassette sub-family B member 6 (ABC-type heme transporter ABCB6) (EC 7.6.2.5) (Mitochondrial ABC transporter 3) (Mt-ABC transporter 3) (P-glycoprotein-related protein) (Ubiquitously-expressed mammalian ABC half transporter) | Disease related genesEnzymesHuman disease related genes | 11 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.38 | |||
| ADA28 | Q9UKQ2 | Disintegrin and metalloproteinase domain-containing protein 28 (ADAM 28) (EC 3.4.24.-) (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II) (eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L) (MDC-L) | Plasma proteinsPredicted membrane proteinsPredicted secreted proteins | 1 | Other mediation | 1 | 0.38 | |||
| ADCY4 | Q8NFM4 | Adenylate cyclase type 4 (EC 4.6.1.1) (ATP pyrophosphate-lyase 4) (Adenylate cyclase type IV) (Adenylyl cyclase 4) | EnzymesMetabolic proteinsPlasma proteins | 12 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.38 | |||
| APLP1 | P51693 | Amyloid beta precursor like protein 1 (Amyloid beta (A4) precursor-like protein 1) (Amyloid-like protein 1) (APLP) (APLP-1) [Cleaved into: C30] | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Receptor-signaling mediation | 1 | 0.38 | |||
| ARMD4 | Q86TY3 | Armadillo-like helical domain-containing protein 4 (Upstream of mTORC2 protein) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.38 | |||
| CA2D2 | Q9NY47 | Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2] | Disease related genesFDA approved drug targetsPredicted intracellular proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.38 | |||
| CABP8 | Q9BXU9 | Calcium-binding protein 8 (CaBP8) (Calneuron I) (Calneuron-1) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediation | 1 | 0.38 | |||
| CAH9 | Q16790 | Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1) | EnzymesFDA approved drug targetsMetabolic proteins | 1 | Clinical-translation mediationMetabolism mediation | 1 | 0.38 | |||
| CC136 | Q96JN2 | Coiled-coil domain-containing protein 136 (Nasopharyngeal carcinoma-associated gene 6 protein) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediation | 1 | 0.38 | |||
| CD37 | P11049 | Leukocyte antigen CD37 (Tetraspanin-26) (Tspan-26) (CD antigen CD37) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 4 | Diffuse large B-cell lymphomaLeukaemiaMalignant haematopoietic neoplasm | Clinical-translation mediation | 1 | 0.38 | ||
| CLCA2 | Q9UQC9 | Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form] | Predicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 1 | 0.38 | |||
| CP20A | Q6UW02 | Cytochrome P450 20A1 (EC 1.14.-.-) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.38 | |||
| CSF1 | P09603 | Macrophage colony-stimulating factor 1 (CSF-1) (M-CSF) (MCSF) (Lanimostim) (Proteoglycan macrophage colony-stimulating factor) (PG-M-CSF) [Cleaved into: Processed macrophage colony-stimulating factor 1; Macrophage colony-stimulating factor 1 43 kDa subunit] | 1 | Inflammatory arthropathySolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 1 | 0.38 | |||
| DSG2 | Q14126 | Desmoglein-2 (Cadherin family member 5) (HDGC) | Disease related genesHuman disease related genesPlasma proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.38 | |||
| EFNB1 | P98172 | Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment (Ephrin-B1 CTF); Ephrin-B1 intracellular domain (Ephrin-B1 ICD)] | Cancer-related genesDisease related genesHuman disease related genes | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.38 |